Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | SÁNCHEZ, ANTONIA REYES |
| Género | Mujer |
| Área Principal WOS | Medicine, General & Internal; |
| Afiliación Principal | Facultad De Medicina |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, General & Internal | 5 |
| Scopus | #Pub |
|---|---|
| Medicine (All) | 5 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 5 |
| Autor | Género | # Pub |
|---|---|---|
| SALDIAS-PENAFIEL, FERNANDO JOSE | Hombre | 3 |
| DIAZ-PATINO, ORLANDO ALBERTO | Hombre | 1 |
| LARA HERNANDEZ, BARBARA | Mujer | 2 |
| SALDÍAS-PEÑAFIEL, FERNANDO | Hombre | 1 |
| ROSSEL, GERARDO SALINAS | Hombre | 1 |
| PATIÑO, ORLANDO DÍAZ | Hombre | 1 |
| FUENZALIDA, PABLO AGUILERA | Hombre | 2 |
| PENALOZA TAPIA, ALEJANDRO | Hombre | 3 |
| CORTES, JOSEFINA | Mujer | 3 |
| CANALES, PABLO URZÚA | Hombre | 1 |
| HERNÁNDEZ, BÁRBARA LARA | Mujer | 1 |
| FUENZALIDA, PABLO AGUILERA | Hombre | 1 |
| URZUA CANALES, PABLO | Hombre | 1 |
| ROSSEL, GABRIEL SALDÍAS | Hombre | 1 |
| HERNÁNDEZ, BÁRBARA LARA | - | 1 |
| FUENZALIDA, PABLO AGUILERA | - | 1 |
| PENAFIEL, FERNANDO SALDIAS | Hombre | 5 |
| TAPIA, ALEJANDRO PENALOZA | Hombre | 4 |
| NESVADBA, DANIELA FARIAS | Mujer | 4 |
| OKSENBERG, KATIA FARCAS | Mujer | 4 |
| MEZA, JOSEFINA CORTES | Mujer | 4 |
| RODRIGUEZ, ISABEL LEIVA | Mujer | 4 |
| REYES SANCHEZ, ANTONIA | Mujer | 4 |
| DIAZ PATINO, ORLANDO | - | 1 |
| PEÑALOZA NESVADBA, DANIELA | - | 1 |
| SALDÍAS PEÑAFIEL, FERNANDO | - | 1 |
| LEIVA RODRÍGUEZ, ISABEL | - | 1 |
| OKSENBERG, KATIA FARCAS | Mujer | 4 |
| ROSSEL, GERARDO SALINAS | - | 1 |
| Palabra Clave | #Pub |
|---|---|
| covid-19 | 3 |
| mortality | 3 |
| pneumonia | 3 |
| prognosis | 3 |
| diagnosis | 3 |
| coronavirus | 3 |
| sars-cov-2 | 2 |
| risk factors | 2 |
| predictive value of tests | 2 |
| validation | 2 |
| management | 1 |
| pronóstico | 1 |
| severity | 1 |
| society | 1 |
| symptoms | 1 |
| outcomes | 1 |
| multicenter | 1 |
| mortalidad | 1 |
| markers | 1 |
| admission decision | 1 |
| lower respiratory-tract | 1 |
| factores de riesgo | 1 |
| economic burden | 1 |
| diseases | 1 |
| criteria | 1 |
| coronavirus disease 2019 | 1 |
| community-acquired pneumonia | 1 |
| community-acquired infections | 1 |
| c-reactive protein | 1 |
| biomarkers | 1 |
| bacteremia prediction model | 1 |